4//SEC Filing
Eaton Bruce 4
Accession 0001415889-22-008463
CIK 0001650664other
Filed
Aug 9, 8:00 PM ET
Accepted
Aug 10, 4:30 PM ET
Size
5.3 KB
Accession
0001415889-22-008463
Insider Transaction Report
Form 4
Eaton Bruce
EVP, Chief Business Officer
Transactions
- Sale
Common Stock
2022-08-09$18.60/sh−293$5,449→ 65,128 total
Footnotes (2)
- [F1]Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on June 15, 2019, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on August 6, 2022. The sale does not represent a discretionary trade by the Reporting Person.
- [F2]This transaction was executed in multiple trades at prices ranging from $18.0525 to $18.61. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Editas Medicine, Inc.
CIK 0001650664
Entity typeother
Related Parties
1- filerCIK 0001874831
Filing Metadata
- Form type
- 4
- Filed
- Aug 9, 8:00 PM ET
- Accepted
- Aug 10, 4:30 PM ET
- Size
- 5.3 KB